ENDPOINTS

Rein Therapeutics study on clinical hold; Beam updates sickle cell therapy data

Plus, news about Enliven Therapeutics, Merck's Keytruda and Celldex: FDA places hold on Rein study: The agency has “non-clinical requests” for Rein Therapeutics’ Phase 2 trial in idiopathic pulmonary fibrosis, per a Thursday ...

Jun 13, 2025 - 15:20
 0
Rein Therapeutics study on clinical hold; Beam updates sickle cell therapy data
Plus, news about Enliven Therapeutics, Merck's Keytruda and Celldex: FDA places hold on Rein study: The agency has “non-clinical requests” for Rein Therapeutics’ Phase 2 trial in idiopathic pulmonary fibrosis, per a Thursday ...
Read More

Tags:

Previous Article

Optimal solvents can boost MOF carrier capacity for precision drug delivery

Next Article

Time to prepare for better floodwater monitoring at Murray Mouth

Related Posts

AnaptysBio describes ‘JAK-like’ efficacy for PD-1 drug in rheumatoid arthritis

AnaptysBio describes ‘JAK-like’ efficacy for PD-1 drug ...

Jun 4, 2025  0

Trump's drug price plan is light on details, may have little impact

Trump's drug price plan is light on details, may have l...

May 12, 2025  0

Bristol Myers gets a key strategist with 'Team Shibs'; Idorsia to change CEOs after it 'hit a reset button'

Bristol Myers gets a key strategist with 'Team Shibs'; ...

Jun 13, 2025  0